Lineage Cell Therapeutics, Inc. (LCTX)

$1.28 +3.64%
EARNINGS ANALYTICS
event_note Approx. Next Earnings: ~2026-08-10 APPROXIMATE
search

Lineage Cell Therapeutics, Inc. (LCTX) has a 20-report earnings history dating back to May 13, 2021. Its average absolute post-earnings move is ±3.16%, and 65.0% of those reactions were positive. Its largest post-earnings gain was +15.25% (Mar 07, 2024) and its largest decline was -4.27% (Mar 10, 2022). The next earnings report is predicted for 2026-08-10 (approximate).

Earnings Price Reaction

Scroll to zoom, drag to pan — click earnings dots for details

Beat Miss

Earnings Impact

Total Earnings

20

Avg Abs. Movement

±3.16%

Positive %

65.0%

Negative %

35.0%

Historical Earnings Statistics

Date Timing Open High Close Volume Movement % SEC Filing
Mar 05, 2026 ☽ POST $1.96 $1.96 $1.84 63,301 -1.36% open_in_new
Nov 06, 2025 ☽ POST $1.81 $1.84 $1.73 41,080 +1.16% open_in_new
Aug 12, 2025 ☽ POST $1.02 $1.03 $1.00 25,852 +2.49% open_in_new
May 13, 2025 ☽ POST $0.47 $0.47 $0.47 32,434 -0.15% open_in_new
Mar 10, 2025 ☽ POST $0.56 $0.58 $0.53 70,486 +0.23% open_in_new
Nov 14, 2024 ☽ POST $0.92 $0.94 $0.89 4,864 -3.62% open_in_new
Aug 08, 2024 ☽ POST $0.87 $0.89 $0.87 12,404 +2.93% open_in_new
May 09, 2024 ☽ POST $1.21 $1.21 $1.17 23,807 +0% open_in_new
Mar 07, 2024 ☽ POST $1.14 $1.14 $1.11 7,676 +15.25% open_in_new
Nov 09, 2023 ☽ POST $1.09 $1.09 $1.07 1,869 -1.87% open_in_new
Aug 10, 2023 ☽ POST $1.47 $1.47 $1.41 5,157 +2.13% open_in_new
May 11, 2023 ☽ POST $1.43 $1.44 $1.42 4,779 -2.11% open_in_new
Mar 09, 2023 ☽ POST $1.45 $1.47 $1.41 17,109 +2.48% open_in_new
Nov 10, 2022 ☽ POST $1.29 $1.35 $1.35 4,158 +6.3% open_in_new
Aug 11, 2022 ☽ POST $1.57 $1.64 $1.52 6,665 +3.29% open_in_new
May 12, 2022 ☽ POST $1.18 $1.23 $1.18 46,732 -4.26% open_in_new
Mar 10, 2022 ☽ POST $1.40 $1.42 $1.41 32,279 -4.27% open_in_new
Nov 10, 2021 ☽ POST $2.50 $2.50 $2.38 8,900 +4.2% open_in_new
Aug 12, 2021 ☽ POST $2.64 $2.65 $2.58 7,072 +0.97% open_in_new
May 13, 2021 ☽ POST $2.37 $2.40 $2.17 35,150 +4.15% open_in_new
event

Earnings Count

20

Total earnings in dataset

trending_up

Avg Abs. Movement

±3.16%

Avg % price change on earnings

description

SEC Filings

View

Browse all SEC filings

SEC Filing Types

Recent SEC Filings

2 most recent
Form Date Filed View on EDGAR
CORRESP 20260319 open_in_new SEC.gov
UPLOAD 20260316 open_in_new SEC.gov

Frequently asked about LCTX earnings

When does Lineage Cell Therapeutics, Inc. report earnings next? expand_more

Lineage Cell Therapeutics, Inc. (LCTX)'s next earnings date is approximate for 2026-08-10. This is a prediction based on its historical quarterly reporting pattern, not a company-confirmed date.

How much does LCTX stock move after earnings? expand_more

Over 20 reports, LCTX has moved an average of ±3.16% the session after earnings, closing higher 65.0% of the time.

What was LCTX's biggest post-earnings move? expand_more

LCTX's largest post-earnings gain on record was +15.25% on Mar 07, 2024, and its largest decline was -4.27% on Mar 10, 2022.

Where can I find Lineage Cell Therapeutics, Inc.'s SEC filings? expand_more

All of Lineage Cell Therapeutics, Inc.'s SEC filings — 10-K, 10-Q, 8-K and more — are listed in the SEC filings section on this page, each linking to the original document on SEC.gov.

Sector peers